Bimatoprost is a synthetic prostamide, structurally linked to prostaglandins F2α. However, the action of reducing IOP in this drug is not related to prostaglandin receptors, but selectively simulating the effect of prostamides. The exact mechanism of action of bimatoprost is not known, because there are no receptors for it in the human body at present. […]